Drug Database
Back to search

Netherlands· NL-99669a71cd1e

Thalidomide BMS 50 mg harde capsules

A thalidomide product containing thalidomide, registered in Netherlands by Bristol-Myers Squibb Pharma EEIG. The same ATC class is registered in 15 of our 19 countries.

ATC L04AX02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedThalidomide BMS 50 mg harde capsulesATCL04AX02REGISTER NO.NL-99669a71cd1ePACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about thalidomideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Thalidomide is registered in 15 of 19 countries.

Countries holding a registration under ATC L04AX02 (thalidomide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search thalidomide products by name

Thalidomide · ATC L04AX02

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
THALIDOMIDE
Manufacturer
Bristol-Myers Squibb Pharma EEIG
Country
Netherlands (NL)
ATC code
L04AX02
ATC class
Thalidomide
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/08/443

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

902 interactions on record for thalidomide.

Graded by severity as the source publishes them — 176 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check thalidomide against other medicinesHow interaction checks work

Thalidomide · interactions on record

902 records

  • 176 severe
  • 583 moderate
  • 143 info

Most severe, free to view

  • PapaverineA03AD01severe
  • PrednisoloneA07EA01severe
  • HydrocortisoneA07EA02severe
  • PrednisoneA07EA03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Thalidomide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All thalidomide products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Cyprus · Thalidomide Accord
  • Germany · Thalidomid Zentiva
  • Denmark · Thalidomid Accord, Thalidomide Zentiva
  • Spain · Taliodmida Accord
  • France · Thalidomide Accord, Thalidomide Koanaa
  • United Kingdom (Northern Ireland) · Thalidomide Accord-Uk, Thalidomide Eugia (Uk)
  • Hungary · Thalidomide Accord
  • Iceland · Thalidomide Bms
  • Italy · Talidomide Accord, Talidomide Aurobindo
  • Liechtenstein · Thalidomide Bms
  • Malta · Thalidomide Accord
  • Norway · Thalidomide Bms, Thalidomide Zentiva
  • Portugal · Talidomida Accord, Talidomida Generis
  • Romania · Talidomidă Accord
  • Sweden · Thalidomide Zentiva
  • Slovenia · Talidomid Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/65c2ee63-2caf-4b30-9bb0-c091e8df5dc6
GET /v1/drugs/65c2ee63-2caf-4b30-9bb0-c091e8df5dc6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/thalidomide-bms-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Thalidomide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp73878",
  "excipients": [
    "AMMONIA (E 527)",
    "GELATINE (E 441)",
    "IJZEROXIDE ZWART (E 172)",
    "KALIUMHYDROXIDE (E 525)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "PROPYLEENGLYCOL (E 1520)",
    "SCHELLAK (E 904)",
    "TITAANDIOXIDE (E 171)",
    "ZETMEEL, GEPREGELATINEERD",
    "ZWARTE INKT"
  ],
  "substances": [
    "THALIDOMIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2008/04/16",
  "procedure_number": "EMEA/H/C/000823",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/08/443",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about thalidomide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console